Health Catalyst, Inc Common Stock (HCAT) is a publicly traded Healthcare sector company. As of August 18, 2026, HCAT trades at $1.82 with a market cap of $139.22M and a P/E ratio of -0.50. HCAT moved -1.89% today. Year to date, HCAT is -22.59%; over the trailing twelve months it is -36.75%. Its 52-week range spans $0.96 to $7.65. Analyst consensus is buy with an average price target of $2.13. Rallies surfaces HCAT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks HCAT insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $1.82 |
| Market Cap | $139.22M |
| P/E Ratio | -0.50 |
| EPS | $-3.70 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.65 |
| 52-Week Low | $0.96 |
| Volume | 154.53K |
| Avg Volume | 0 |
| Revenue (TTM) | $292.25M |
| Net Income | $-264.82M |
| Gross Margin | 0.00% |
5 analysts cover HCAT: 0 strong buy, 2 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.13.